CareLit Fachartikel
Economic Evaluations of Treatment Options in Patients with Alzheimer's Disease – A Systematic Review
Pouryamout, L.; Neumann, A.; Dams, J.; Wasem, J.; Dodel, R. · Das Gesundheitswesen · 2011 · Heft 8/09 · S. 1 bis 1
Dokument
349554
CareLit-ID
Jahr
2011
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Aim of the study: Alzheimer's disease (AD) is one of the most common diseases for the elderly with 60–80% of all dementia patients. By 2030 it is predicted that the number of people suffering from AD will increase to 65.7 million. With this increase, also the costs are going to rise. In 2010 the worldwide costs of dementia are estimated to US$604 billion. The objective of this study is to conduct a systematic review on pharmacoeconomic studies of drug treatment options in patients with AD. Methods: A systematic literature search was performed including a time frame from January 1st 2007 to July 15th 2010, based…
Schlagworte
Alzheimer-Krankheit
wirtschaftliche Bewertung
Arzneimitteltherapie
systematische Überprüfung
Kosten-Nutzen-Analyse
Donepezil
Memantin
Galantamin
Alzheimer Disease
Drug Therapy
Cost-Benefit Analysis
Economic Evaluation
Memantine
Galantamine
Das Gesundheitswesen
